GRFS (Grifols SA) Net Profit

GRFS (Grifols) - company brandmark

The financial profit of Grifols, S.A. (GRFS), as provided by the GURU.Markets platform, demonstrates profit dynamics where the parameter value equals 0.53. Grifols, S.A. (GRFS) revenues are based on global leadership in plasma processing and vertical integration. Robotic protein purification lines support business stability, while supply reliability is guaranteed by strict adherence to temperature regimes during the air transport of pharmaceuticals.

GRFS (Grifols, S.A.) Net Profit history from 07/04/2022 to 10/30/2026
Core merchandise of Grifols Group

As a global leader in plasma-derived medicines with an impeccable biosafety record, Grifols, S.A. (GRFS) generates cash flows directly dependent on raw material processing volumes. This metric measures the final financial result after deducting all expenses; therefore, analyzing the company's net operating profit allows for a distinction between short-term volatility and a systemic compression of business margins.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|ADPT - Company Net Income|celldex.com (CLDX) - Net Income|Aurinia Pharmaceuticals Inc. (AUPH) - Company Net Income|Net Income BioCryst Pharmaceuticals, Inc.|Net Income VERA|Net Profit Dianthus Corp|Company Net Income Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Company Profit|Net Profit TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Company Net Income|Pharming - Net Profit|Annual Net Income Nektar Corp (NKTR)|Upstream Bio Inc (UPB) - Company Net Income|zenasbio.com - Final Profit|IMNM (Immunome) - Net Profit|Gossamer Bio Inc (GOSS) - Net Financial Result|Net Profit KALV|SEPN: Profit After Tax|Company Net Income Pieris Pharmaceuticals PVLA|savarapharma.com (SVRA) - Company Net Income|RIGL - Company Net Income|ANAB: Company Net Income|Astria Pharma (ATXS) - Company Net Income|ENGN - Net Financial Result|Net Income RAPT|JBIO: Final Profit|Company Net Income Aclaris Therapeutics, Inc. (ACRS)|Net Financial Result Kyverna Therapeutics Inc.|Tiziana Life Sciences PLC - Net Income|Net Financial Result Cabaletta Bio Inc (CABA)|Ventyx Biosciences - Net Profit|THTX - Net Profit|AVTX (Avalo Therapeutics) - Net Income|ELDN - Net Financial Result|AGEN (Agenus Inc) - Net Profit|CLYM - Annual Net Income|Company Net Income Zura Bio Limited (ZURA)|ATYR (atyrpharma.com) - Final Profit|Net Profit ADAG (Adagene Inc.)|IMA (ImageneBio) - Profit After Tax|STTK - Company Net Income|Net Financial Result Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Company Net Income|Profit After Tax IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Net Profit|IFRX: Final Profit|Net Profit XFOR|Net Profit adicetbio.com (ACET)|Company Net Income Celularity CELU|Final Profit INMB|BRNS - Company Net Income|Kezar Life Sciences Inc. (KZR) - Net Income|SABS: Net Profit|Akari Therapeutics, Plc (AKTX) - Net Profit|Net Income ENLV|QTTB: Final Profit|Net Profit GOVX|Net Financial Result Edesa Biotech Inc|Company Net Income iBio Corp IBIO|CARM - Net Income|XTLB - Company Net Income|Bolt Biotherapeutics (BOLT) - Net Income|HCWB (hcwbiologics.com) - Net Income|Aptevo Therapeutics Inc. (APVO) - Net Profit|Company Net Income AIM ImmunoTech|Company Profit ADTX (Aditxt Corp)|Net Profit GRI|XRTX - Company Net Income|Net Profit HIND (Vyome Holdings)|Annual Net Income Revelation Biosciences Inc|INDP - Company Net Income|Final Profit SCNI (BiondVax Pharmaceuticals)|CALI: Net Profit|AFMD - Net Financial Result|ALLK (Allakos Inc) - Net Profit|HOOKIPA - Profit After Tax|Company Net Income IGM Biosciences, Inc. (IGMS)|ITOS - Company Net Income|Company Net Income Ocean Biomedical, Inc. OCEA|tcbiopharm.com - Company Net Income|THRD - Company Net Income